GGrantIndex
← Search

The Adaptive COVID-19 Treatment Trial (ACTT)

$18,166,213N01FY2020CANIH

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Abstract

To support randomized, controlled clinical trials to evaluate the safety and efficacy of investigational antiviral drugs against COVID-19.

View original record on NIH RePORTER →